PMID- 10532970 OWN - NLM STAT- MEDLINE DCOM- 19991222 LR - 20190905 IS - 1464-4096 (Print) IS - 1464-4096 (Linking) VI - 84 IP - 7 DP - 1999 Nov TI - Chromosomal aberrations in transitional cell carcinoma that are predictive of disease outcome are independent of polyploidy. PG - 775-9 AB - OBJECTIVE: To determine whether aneusomy for chromosomes 7, 9 and 17 (reported to predict recurrence in up to 65% of patients with superficial transitional cell bladder cancer and thus providing the opportunity for early and effective treatment) reflects specific genetic events on these chromosomes or merely wider unspecific genetic damage to the cell, e.g. that increased copy numbers for 7 and 17 reflect tumour polyploidy. MATERIALS AND METHODS: The study comprised 25 primary tumours; 6 microm thick sections from formalin-fixed and paraffin-embedded tumours were analysed. Chromosome copy numbers were determined by fluorescence in situ hybridization (FISH) using pericentromeric probes for chromosomes 7, 8, 9, 10, 11 and 17. A minimum of 200 nuclei per tumour area were scored by two independent observers. RESULTS: Eight of the 25 tumours examined (32%) showed no evidence of chromosomal abnormalities as detected by FISH for any chromosomes analysed. Twelve tumours (48%) showed abnormalities for one or two chromosomes, five tumours (20%) showed abnormalities for multiple chromosomes and one tumour showed abnormalities for all chromosomes analysed, suggestive of polyploidy. CONCLUSIONS: Chromosomal abnormalities predictive of recurrence occur largely in the absence of other gross chromosomal lesions. In a small proportion of cases other chromosomes are affected, but this is almost always distinct from tumour polyploidy. FAU - Bartlett, J M AU - Bartlett JM AD - University Department of Surgery, Glasgow Royal Infirmary, Scotland, UK. gqva20@udcf.gla.ac.uk FAU - Adie, L AU - Adie L FAU - Watters, A D AU - Watters AD FAU - Going, J J AU - Going JJ FAU - Grigor, K M AU - Grigor KM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - BJU Int JT - BJU international JID - 100886721 SB - IM MH - Carcinoma, Transitional Cell/*genetics MH - Chromosome Aberrations/*genetics MH - Chromosomes, Human, Pair 17/genetics MH - Chromosomes, Human, Pair 7/genetics MH - Chromosomes, Human, Pair 9/genetics MH - Humans MH - In Situ Hybridization, Fluorescence/methods MH - Neoplasm Recurrence, Local/genetics MH - Neoplasm Staging/methods MH - *Polyploidy MH - Prognosis MH - Retrospective Studies MH - Urinary Bladder Neoplasms/*genetics EDAT- 1999/10/26 00:00 MHDA- 1999/10/26 00:01 CRDT- 1999/10/26 00:00 PHST- 1999/10/26 00:00 [pubmed] PHST- 1999/10/26 00:01 [medline] PHST- 1999/10/26 00:00 [entrez] AID - bju268 [pii] AID - 10.1046/j.1464-410x.1999.00268.x [doi] PST - ppublish SO - BJU Int. 1999 Nov;84(7):775-9. doi: 10.1046/j.1464-410x.1999.00268.x.